Member Info for Bella6532

Pd295...it all depends on whether or not one or both were working with Avacta on a potential funding deal prior to their appointments.

Remember one has a shareholding interest and the other is worked alongside one of our Directors for a few years in another company do they are not unknown knowns. If they signed Insider/NDA's they could well have had access to the accounts/data some time back and their appointments go hand in hand with a financial deal. This week has simply been dotting I's and crossing T's especially if a financial deal was put on the table just as the audtors were closing out and it changed their whole outlook. If such a deal is also to clear the Bond then again this would need working around with Bond holder and auditors.

What happened this week hasn't spooked the markets so let's wait and see what 7am tomorrow brings...

B2HS2L...'Bella, agree with sacking Michael Vinegrad. - He's done sweet FA.'...

I have sent him several EMails now pointing out where updates/corrections might be needed on the Avacta website. He instantly updated the first but the rest have been ignored.

Investors Section still has Forster as Chairman and old FD...now it might be the case they can't update until after AGM and if that's the case why not respond to that effect. I received absolutely no response to any Emsils I sent.

It's about time they dumped Michael Vinegrad, Group Communications Director.

Avacta wants Finance deals right now...

They have already said they want to take AVA6000 to market themselves so that's where Healthcare Royalty comes in. Check out the sorts of deals they've been doing in the past 6 months or so...

Now if pipeline Licence deals come in down the road then Healthcare Royalty could be in for a % of the royalties etc depending on the sort of upfront deal they do now with Avacta.

They also do refinancing deals so they are possibly in a strong position to work something out to clear the Bond deals.

If Bryant and Hughes do what we hope they will do, we could see some very interesting Alliance Agreements/Funding Arrangments come our way plus that Nasdaq Listing/RTO announced.

As always, we are left guessing and will only know for sure tomorrow morning and over the next few months as more news drops.

On the other hand ASCO is May 30 - June 3, 2025.

Results moved from 29th May to 4 June...why? Is ASCO the reason?

Esspeksy...'I can't see anywhere Avacta attending.

Have I missed something? Thought they were due to go?'

If they've secured finance and a partnership deal is in the final stages...why present at ASCO if said partner will be there...

Yeah...smashed and off the hinges...

Thump... number 8...

Cummon guys burst that door open...

Metatron...lighten up, it's happy hour somewhere dude...geez...

Victory...every sell has a buy or buys...don't worry about it hun.

It's been banging on the 40 door all day..let's see if a shoulder shove can break it open tomorrow.

Bline59..no the rich are getting richer due to Globalisation and QE...

Hughes knows much more about Avacta than perhaps some might think. He was/is a shareholder and remember Medusa...unfortunately that didn't work out but this time will be very different.

Almost 10m trades total in last two days...nice...😉

This was mid April...??!!!

https://x.com/Littleboyblue75/status/1913141812509733173

It's probably the one buying lkke made to close part or all of it's position...haha

Livedataaccount...it looks like we've got our answers...did you not wonder why it was so important to dump DX...income streams purely into TX (no grey areas re costs/distribution etc). Their business model is taking a cut of future Royalties...not profit...so they'd be looking to see deals with Pharma on a licencing/royalty basis. They're also US based to hence Nasdaq listing.

This really feels like these guys have been working with Avacta in the background for some time...and my guess is we will start to see more unfold in coming weeks not months now they've gone public so to speak...

Just need a nice little Nasdaq Listed company to reverse into now...

Healthcare Royalty last deal...

'HealthCare Royalty has agreed to acquire a portion of royalties on net sales of Iqirvo due to Genfit from Ipsen (which holds global commercial rights to Iqirvo outside certain Asian countries) pending achievement of certain closing conditions. The transaction meaningfully extends Genfit’s cash runway, allowing the Company to repay its outstanding convertible bonds and continue to invest in its wholly-owned pipeline of development candidates focused on the treatment of Acute-on-Chronic Liver Failure (ACLF).'

So is this why Avacta want to take AVA6000 to market themselves...Finance enabling them to move forward and clear bond based on share of future royalties and all based on data which might now be good enough to show their hands and take up board seat???

Is Hughes still a shareholder? The who Medusa was rather a shambles wasn't it?

I guess these two appointments would have been in the works for some time, hence the apparent confidence Avacta seemed to have towards future funding.

I wonder how many Fudders will now suddenly disappear or turn into amazing rampers...mmm! who were they really working for!!!!

Let's hope the announcement this morning is followed quickly with some large dollops of cash.

Daewoong Investment Bio Investment Association No. 1 is a venture capital fund managed by Daewoong Investment. The fund is located in China. The fund targets life sciences sector.

Contact Information

Fund Manager

Daewoong Investment

Fund Category

Venture Capital

Close Date

Fund Family

Daewoong Investment Bio Investment Association

Native Currency

KRW

Fund Manager's Location

China

Fund Domiciles

South Korea

Perhaps a little dot joining is required...

Hanall Biopharma have branched out into Oncology.

They are part of Daewoong Pharma and Daewoong Investment...and there is very much a Chinese connection...